Summary Chromosome damage in vitro after bleomycin treatment during the late S and G2 phases of the cell cycle was studied in the peripheral lymphocytes of 19 untreated patients with primary testicular tumours and 22 age-matched healthy men with no excess of cancer incidence in the families. The occurrence of spontaneous chromosome aberrations was not shown to be different in the studied groups. However, in the lymphocytes treated with bleomycin, cancer patients exhibited higher numbers of break events per cell (Senturia, 1987) . Ethnic disposition, early age of onset, high bilateral incidence of familial TC, some HLA studies and observations in identical twins suggest a hereditary influence in the aetiology of TC (Dieckmann et al., 1987) .
The existence of several rare chromosome-breakage syndromes indicates that genetic instability may increase the probability of mutational events and thus play an important role in oncogenesis (German, 1983; Hsu, 1987) . Since cellular responses to mutagen action, such as DNA repair and replication, are thought to be under the control of many genes in mammalian cells, a gradient of genetic instability could exist in the population (14su, 1983) . Both human tumour cells and skin fibroblasts or blood lymphocytes derived from patients with a number of cancer-prone genetic disorders, when X-irradiated during the G2 phase of the cell cycle, have more chromatid breaks and gaps during the postirradiation period than comparable cells from unaffected individuals (Parshad et al., 1983 (Parshad et al., , 1984 Sanford et al., 1987) . Acquisition of enhanced G2 chromatid radiosensitivity by normal cells may be an early step in their neoplastic transformation in culture (Gantt et al., 1987b) . Biochemical and cytogenetic studies indicate that this increased chromatid damage results from deficient DNA repair (Parshad et al., 1982; Gantt et al., 1987a; Hsu et al., 1986) .
Increased bleomycin-induced chromatid damage in G2 peripheral lymphocytes of some cancer patients has repeatedly been reported by Hsu et al. (1985 Hsu et al. ( , 1987 and Cherry & Hsu (1983) . We used this radiomimetic agent to expose the late S and G2 lymphocytes of untreated Caucasian patients with the primary TC.
Materials and methods
Patients and controls To avoid any diagnostic or therapeutic mutagen exposure and possible synergic effects of X-irradiation in vivo and bleomycin treatment in vitro (Alalawi & Chapman, 1977) In both groups a differential response in the number of break events per cell was documented (Figure 1) , ranging from 0.36 to 2.21 in cancer patients and from 0.14 to 1.29 in controls, but means differed significantly (P=0.004). There were no differences in number of break events per cell between patients with seminomas and non-seminomas, between the patients with one or more cancer among the second degree relatives and without family history of cancer, and there was no correlation with the laterality of TC.
The patients with more advanced TC at diagnosis (nine patients with stage III and higher; Harmer, 1978) The distribution of break events on the chromosome arms showed that the long arm of chromosome 1 was affected more frequently in TC patients (12.0% versus 6.3%, P<0.0001) and that it contributes mainly to the increased chromosome 1 instability (Figure 3 ). Elevated levels were found for the short arm of chromosome 3 (P < 0.001, F-test) and a lower frequency for the short and long arms of chromosome group C (P<0.01, P<0.05, respectively).
The ratio of short-arm break events/long-arm break events did not reveal a statistical difference between controls and patients. In both groups a comparable proportion of unclassified chromatid breaks was recorded (16% in control group and 15% in cancer patients).
Two and more times repeated break points of chromosome 1-3 found in individuals of control sample (a) and cancer group (b) are shown in Figure 4 . The most frequent regions affected were lq2, lq3, and 2q3.
Discussion
Our results showing a differential response to BLM action further support the hypothesis of a gradient of genetic instability in population (Hsu, 1983) . The broad interindividual variability to BLM can be explained on several levels: cellular uptake of the agent, its intracellular metabolism, direct or indirect action on the DNA and the cellular response to genetic damage. Only limited information is available on BLM uptake and its metabolic inactivation. Increased levels of bleomycin hydrolase, an aminopeptidase which inactivates BLM, have been reported in BLM resistant rat hepatoma cells; other studies showed no difference in hydrolase activity (for review see Sikic, 1986) .
The extent to which variability in DNA repair mechanisms Chromosome number and arm Figure 3 Distribution of break events on the arms of chromosomes 1-3. contributes to differences in BLM-induced chromosomal damage is not exactly known. Studies of Saccharomyces cerevisiae suggest that at least 13 genes may be involved in the repair of BLM-induced DNA damage. The experiments with BLM and aphidicolin support a differential repair capacity among humans (Hsu et al., 1986) , possibly corresponding to the variability found after BLM-induced chromatid damage. Nevertheless, it seems to be of primary importance to consider and detect all the factors affecting G2 BLM-induced chromatid sensitivity, including the modulators of BLM cytotoxicity (Sikic, 1986) and technical or laboratory artifacts. Previous radiation exposure of patients was entirely avoided in our study, but it is not likely that a low dose in vivo after diagnostic X-ray could exert an influence on final cell breakage after such a high dose of BLM in vitro. At present, the described test does not seem to be sufficiently effective in identifying individuals disposed to TC. To further improve its sensitivity and specificity, mutagens with different mechanisms of action should be used (Hsu, 1987) . The abnormalities of chromosome 1 are very frequent in many, if not all, cancer cells (Atkin, 1986) , including testicular tumours (Wang et al., 1980; DeLozier-Blanchet et al., 1987) . Break points of chromosome 1 are non-random, being concentrated in the regions of p12, q12, p36 and p22 (Wang et al., 1980) . However, the bands most often affected in the lymphocytes of our cancer patients seemed to be quite distinct from those found in cancer cells. Our findings of a more frequently involved chromosome 1 (lq) and 3 (3p) after non-specific DNA damage indicate that in this region the genotype disposed to TC may be either more susceptible to damage or less effective in its ability to repair it (for review see Bohr et al., 1987) . Combination treatment with BLM and aphidicolin (Hsu et al., 1986) indicates that under given conditions, BLM induces approximately the same number of DNA lesions. Furthermore, the relationship between a disposition to the germ-cell gonadal tumours and DNA repair is of particular interest with respect to the maintenance of DNA in the germ line. It is conceivable that in the lymphocytes of patients with other solid tumours a similar increase in chromosome 1 breakage could be found. The possible relationship between the fragile site at 3p14 and the increased breakage of 3p in our cancer patients remains to be elucidated.
Isochromosome i(12p) is considered a possible specific marker of gonadal germ cell tumours (Atkin & Baker, 1983;  .^^1% 1% 11 A It n -P"n DeLozier-Blanchet et al., 1987) . We did not determine an involvement of chromosome 12 in breakage, but we observed slightly more frequent chromosome instability of groupF, corresponding in size to this isochromosome.
